Excerpt: HIV resistance testing is an important part of evaluating treatment options for people diagnosed with HIV. The test can identify genetic changes in the virus that may reduce the effectiveness of certain antiretroviral medicines. Understanding resistance patterns before starting treatment may help healthcare professionals select an appropriate combination of medicines. This article explains the purpose of HIV resistance testing, when it may be recommended, the main types of tests, and how results can support treatment planning. It provides general educational information and does not replace personalized advice from a qualified healthcare professional.
HIV treatment has changed significantly over the years, and modern antiretroviral therapy can effectively suppress the virus for many people. Before treatment begins, healthcare professionals may perform several laboratory tests to better understand an individual's health and the characteristics of the virus. HIV resistance testing is one of these assessments and can provide useful information about whether the virus has genetic changes associated with reduced sensitivity to specific HIV medicines.
Drug resistance can occur when HIV develops changes, known as mutations, that affect how well certain antiretroviral medicines work against it. A person may acquire a strain of HIV that already contains resistance-related mutations, or resistance can develop over time in certain circumstances. Testing before starting treatment can help guide the selection of medicines and support an informed approach to HIV care.
HIV resistance testing examines the genetic characteristics of the virus to identify mutations associated with resistance to particular antiretroviral drugs. The information can help healthcare professionals understand whether some medicines may be less suitable for a person's treatment regimen.
Resistance testing is generally considered alongside other important assessments, such as HIV viral load, CD4 cell count, medical history, previous treatment exposure, and potential interactions with other medicines. The results are interpreted by qualified healthcare professionals as part of an overall treatment plan.
The results of resistance testing do not simply identify whether HIV is resistant or nonresistant. They are interpreted in relation to specific medicines and drug classes. A healthcare professional may use this information to select a combination of antiretroviral medicines that is expected to remain effective against the individual's virus.
Starting HIV treatment involves more than choosing a single medicine. Antiretroviral therapy usually uses a combination of medicines that work in different ways to suppress HIV replication. Resistance test results can provide additional information that supports the selection of an appropriate regimen.
In many cases, resistance testing is performed as close as possible to the time of HIV diagnosis or before treatment is started, depending on clinical circumstances and local healthcare guidelines. The timing and type of testing may vary based on a person's medical history and the availability of laboratory services.
HIV resistance testing is one component of comprehensive HIV care. When combined with appropriate medical evaluation, treatment selection and ongoing monitoring, it can provide valuable information for managing HIV infection. People who have questions about HIV testing or treatment options can discuss their individual circumstances with a qualified healthcare professional.